150 - Substance induced psychotic disorders
Substance-induced psychotic disorders
489 Disorders due to substance use or addictive behaviours Substance-induced delirium Available categories by substance class 6C40.5 Alcohol-induced delirium 6C41.5 Cannabis-induced delirium 6C42.5 Synthetic cannabinoid-induced delirium 6C43.5 Opioid-induced delirium 6C44.5 Sedative, hypnotic or anxiolytic-induced delirium 6C45.5 Cocaine-induced delirium 6C46.5 Stimulant-induced delirium, including amfetamines, methamfetamine and methcathinone 6C47.5 Synthetic cathinone-induced delirium 6C49.4 Hallucinogen-induced delirium 6C4B.5 Volatile inhalant-induced delirium 6C4C.5 MDMA or related drug-induced delirium, including MDA 6C4D.4 Dissociative drug-induced delirium, including ketamine and PCP 6C4E.5 Delirium induced by other specified psychoactive substances, including medications 6C4F.5 Delirium induced by multiple specified psychoactive substances, including medications 6C4G.5 Delirium induced by unknown or unspecified psychoactive substances CDDR for substance-induced delirium are provided as part of the grouping of neurocognitive disorders (delirium due to psychoactive substances, including medications, p. 606). Substance-induced psychotic disorders Available categories by substance class 6C40.6 Alcohol-induced psychotic disorder 6C41.6 Cannabis-induced psychotic disorder 6C42.6 Synthetic cannabinoid-induced psychotic disorder 6C43.6 Opioid-induced psychotic disorder 6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder 6C45.6 Cocaine-induced psychotic disorder 6C46.6 Stimulant-induced psychotic disorder, including amfetamines, methamfetamine and methcathinone 6C47.6 Synthetic cathinone-induced psychotic disorder 6C49.5 Hallucinogen-induced psychotic disorder 6C4B.6 Volatile inhalant-induced psychotic disorder 6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA 6C4D.5 Dissociative drug-induced psychotic disorder, including ketamine and PCP 6C4E.6 Psychotic disorder induced by other specified psychoactive substance 6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances 6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive substances Substance-induced mental disorders | Delirium | Psychotic disorders
Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders Essential (required) features • The presentation is characterized by psychotic symptoms (e.g. delusions, hallucinations or disorganized thinking or behaviour) that develop during or soon after intoxication with or withdrawal from a specified substance, or use or discontinuation of a psychoactive medication. • The intensity or duration of the psychotic symptoms is substantially in excess of psychoticlike disturbances of perception, cognition or behaviour that are characteristic of intoxication or withdrawal due to the specified substance. • The specified substance, as well as the amount and duration of its use, is known to be capable of producing psychotic symptoms (see the list above and Table 6.14, p. 454). • The symptoms are not better accounted for by another mental disorder such as schizophrenia or a mood disorder with psychotic symptoms. Evidence supporting a diagnosis of another mental disorder would include psychotic symptoms preceding the onset of the substance use, the symptoms persisting for a substantial period of time after cessation of the substance, or medication use or withdrawal (e.g. 1 month or more depending on the specific substance), or other evidence of a pre-existing mental disorder with psychotic symptoms (e.g. a history of prior episodes not associated with substance use). • The symptoms are not a manifestation of another medical condition. • The symptoms result in significant distress or significant impairment in personal, family, social, educational, occupational or other important areas of functioning. Specifiers for substance-induced psychotic symptoms An additional specifier can be added to denote the presence of hallucinations, delusions, or mixed psychotic symptoms for alcohol-induced psychotic disorder (6C40.6), cocaine-induced psychotic disorder (6C45.6), stimulant-induced psychotic disorder, including amfetamines, methamfetamine or methcathinone (6C46.6), and synthetic cathinone-induced psychotic disorder (6C47.6). The x below corresponds to the fourth-character code indicating the substance class (0 for alcohol, 1 for cannabis and so on) (see the list above and Table 6.14, p. 454). Substance-induced psychotic disorder with hallucinations • All diagnostic requirements for substance-induced psychotic disorder are met. • The presentation is characterized by hallucinations that are judged to be the direct consequence of the use of or withdrawal from a specified substance or medication. • Neither delusions nor other psychotic symptoms are present. • The symptoms do not occur exclusively during hypnogogic or hypnopompic states. Substance-induced mental disorders | Psychotic disorders 6C4x.60
No comments to display
No comments to display